1 |
Zieman, M., S. K. Fong, N. L. Benowitz, D. Banskter and P. D. Darney. 1997. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet. Gynecol. 90:88-92.
DOI
ScienceOn
|
2 |
Product Information. 2005. . Pfizer Inc. New York.
|
3 |
Qazi, R. A. 2006. Congenital anomalies associated with failed misoprostol termination of pregnancy. J. Liaquat Uni. Med. Health Sci. 5(3):122-124.
|
4 |
Robert, A., J. E. Nezamis and J. P. Phillips. 1967. Inhibition of gastric secretions by prostaglandins. Am. J. Dig. Sci. 12:1073-1076.
DOI
|
5 |
Rozenberg, P., S. Chevret, F. Goffinet, I. Durand, Y. Ville, C.Vayssiere, A. Roberto, Z. Lahna, I. Nisand, C. Fisch, P. Chaumet-Riffaud and C. Chastang. 2001. Induction of labor with a viable infant: a randomized clinical trial comparing intra-vaginal dinoprostone. Br. J. Obstet. Gynecol. 108:1256-1262.
|
6 |
Shetty, A., P. Danielian and A. Temleton. 2002. Sublingual compared with oral misoprostol in term labor induction: a randomized controlled trial. Br. J. Obstet. Gynecol. 109:645-650.
DOI
|
7 |
Shetty, A., I. Livingstone, S. Acharya, P. Rice, P. Danielian and A. Templeton. 2003. Oral misoprostol (100 ) versus vaginal misoprostol (25 ) in term labor induction: a randomized comparison. Acta. Obstet. Gynecol. Scand. 82:1103-1106.
DOI
ScienceOn
|
8 |
Song, J. 2000. Use of misoprostol in obstetrics and gynecology. Obstet. Gynecol. Surv. 55:503-510.
DOI
ScienceOn
|
9 |
Tang, O. S., H. Schweer, H. W. Seyberth, S. W. Lee and P. C. Ho. 2002. Pharmacokinetics of different routes of misoprostol. Hum. Reprod. 17:332-336.
DOI
ScienceOn
|
10 |
Uzumcu, A., B. Karaman, G. Toksoy, Z. O. Uyguner, S. Candan, H.Eris, B. Tatli, B. Gechinli, A. Yuksel, H. Kayserili and S.Basaran. 2009. Molecular genetic screening of MBS1 locus on chromosome 13 for microdeletions and exclusion of FGF9, GSH1 and CDX2 as causative genes in patients with Mobius Sybdrome. Eur. J. Med. Genet. 52(5):315-320.
DOI
ScienceOn
|
11 |
Jonakait, G. M. and L. Ni. 2009. Progstaglandins compromise basal forebrain cholinergic neuron differentiation and survival: action at EP 1/3 receptors result in AIF induced death. Brain Res. 1285:30-41.
DOI
ScienceOn
|
12 |
Jost, A. 1986. New data on the hormonal requirements of the pregnant rabbit: partial pregnancies and fetal abnormalities\ after treatment with a hormonal antagonist at subabortifacient doses. C. R. Acad. Sci. 303(Series III NO. 7):281-284.
|
13 |
Khan, R. and H. El-Rafaey. 2003. Pharmacokinetics and adverse effects profile of rectally administered misoprostol in the third stage of labor. Obstet. Gynecol. 101:968-974.
DOI
ScienceOn
|
14 |
McEvoy, G. K. 1996. American hospital formulatory service-drug information 96. Bathesda, MD: American Society of Health System Pharmacist Inc. (Plus supplements). p. 2171.
|
15 |
Meckstroth, K. R., A. K. Whitaker, S. Bertisch, A. B. Goldberg and P. D. Darney. 2005. Misoprostol administered through epithelial route. Obstet. Gynecol. 108:82-90.
|
16 |
Middleton, T., E. Schaff, S. L. Fielding, M. Scahill, C. Shannon, E.Westheimer, T. Wilkinson and B. Winikoff. 2005. Randomized trial of mifepristone and buccal or vaginal menstrual period. Contraception 72:328-332.
DOI
ScienceOn
|
17 |
Nopdonrattakoon, L. 2003. A comparison for labor induction: a randomized controlled trial. J. Obstet. Gynecol. Res. 29:87-91.
DOI
ScienceOn
|
18 |
Norman, J. E., K. J. Thong and D. T. Baird. 1991. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 338:1233-1236.
DOI
ScienceOn
|
19 |
Paungmora, N., Y. Herabutya, P. Prasertsawat and P. Punyavachira. 2004. Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial. J. Obstet. Gynecol. Res. 30:358-362.
DOI
ScienceOn
|
20 |
Product Information. 2009. . Pfizer Australia Private, Limited.
|
21 |
Foote, E. F., D. R. Lee, A. Karim, W. F. Keane and C. E.Halstenson. 1995. Disposition of misoprostol and its active metabolite inpatients with normal and impaired renal function. J. Clin. Pharmacol. 35:384-389.
DOI
ScienceOn
|
22 |
Ginath, S. and H. Zakut. 2001. Misoprostol-for cervical ripening? Eur. J. Obstet. Gynecol. Reprod. Biol. 99:152-153.
DOI
ScienceOn
|
23 |
Goldberg, A. B., B. S. Greenberg and P. D. Darney. 2001. Misoprostol and pregnancy. N. Eng. J. Med. 343:38-48.
|
24 |
Gonzalez, C. H., M. J. Marques-Dias, C. A. Kim, S. M. Sugayama,J. A. Dal pizzol, S. M. Huson and L. D. Holmes. 1998. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet, 351(9116):1624-1627.
DOI
ScienceOn
|
25 |
Henriques, A., A. V. Lourenco, A. Riberiniho, H. Ferreira and L. M. Graca. 2007. Maternal death relate to misoprostol overdose. Obstet. Gynecol. 109:489-490.
DOI
|
26 |
Gonzalez, C. H., F. R. Vargas, A. B. Perez, C. A. Kim, D. M. J.Brunoni, Marques-Dias, C. R. Leone, J. Correa Neto, J. C.Llerena and J. C. de Almaida. 1993. Limb deficiency with or without mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am. J. Med. Genet. 47(1):59-64.
DOI
ScienceOn
|
27 |
Hemminki, E., T. Luostarinen, E. Pukkala, D. Apter and T. Kakulinen. 2002. Oral contraceptive use before first birth and risk of breast cancer: a case control study. BMC Women’s Health 2:9.
DOI
ScienceOn
|
28 |
Ho, P. C., S. W., Ngai, K. L. Liu, G. C. Wing and S. W. Lee. 1997.Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet. Gynecol. 90:735-738.
DOI
ScienceOn
|
29 |
Javed, L., M. Maik, N. Jamal, S. Sheikh and F. Farzana. 2004. Mid-trimester termination of pregnancy-comparison of sublingual with vaginal misoprostol. Biomedica 20:56-59.
|
30 |
Castleman, L. D., K. T. Oanh, A. G. Hyman, T. Thuy le and B. D.Blumenthal. 2006. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol. Contraception 74:272-276.
DOI
ScienceOn
|
31 |
Coelho, K.-E. F. A., M. V. F. Barmento, C. M. Veiga, C. E. Speck-Martins, H. P. N. Safattle, C. V. Castro and N. Niikawa. 2000. Misoprostol embryotoxicity: Clinical evaluation of fifteen patients with arthrogryposis. Am. J. Med. Genet. 95(4):297-301.
DOI
ScienceOn
|
32 |
Collins, P. W. 1990. Misoprostol: discovery, development and clinical applications. Med. Res. Rev. 10:149-172.
DOI
ScienceOn
|
33 |
CSGN, 2006. http://www.csgnetwork.com/glossary/html#calculator
|
34 |
Dal Pizzol, T. S., F. P. Knop and S. S. Mengue. 2006. Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta analysis. Reprod. Toxicol. 22:666-671.
DOI
ScienceOn
|
35 |
Dal Pizzol, T. S., M. T. V. Sanseverino and S. S. Mengue. 2008. Exposure to misoprostol and hormones during pregnancy and risk of congenital anomalies. Cad. Saude. Publica 24(6):1447-1453.
DOI
|
36 |
Deraedt, R., B. Vannier and R. Fournex. 1985. Toxicological study on RU 486. In: The antiprogestin steroid RU 486 and human fertility control (Ed. E. E. Baulieu and S. J. Segal). New York, Plenum Press. pp. 123-126.
|
37 |
Derman, R. J., B. S. Kodkany, S. S. Goudar, S. E. Geller, V. A.Naik, M. B. Bellad, S. Patted, A. Patel, S. Edlavitch and T. Hartwell. 2006. Oral misoprostol in preventing postpartum hemorrhage in resource-poor communities: a randomized controlled trial. Lancet 368:1248-1253.
DOI
ScienceOn
|
38 |
El-Rafaey, H., D. Rajasekar, M. Abdalla, L. Calder and A. Templeton. 1995. Induction of abortion with mifepristone (RU 486) and oral and vaginal misoprostol. N. Eng. J. Med., 332:983-987.
DOI
ScienceOn
|
39 |
Adair, C. D. and D. F. Lewis. 1998. Labor induction with oral versus vaginal misoprostol: a randomized double-blind trial. Am. J. Obstet. Gynecol. 92:810-813.
DOI
ScienceOn
|
40 |
Al-Hussaini, T. 2001. Uterine rupture in second trimester abortion in a grand multiparous woman: A complication of misoprostol and oxytocin. Eur. J. Obstet. Gynecol. Rerpod. Biol. 96(2):218-219.
DOI
ScienceOn
|
41 |
Andolina, K. L., J. E. Tolosa, J. M. Monzo, N. S. Roberts and S. Daly. 2003. Oral misoprostol is rapidly absorbed in postpartum women at term. J. Matern. Fetal Neonatal. Med. 14:229-232.
DOI
ScienceOn
|
42 |
Berghahn, L., D. Christensen and S. Droste. 2001. Uterine rupture during second trimester abortion associated with misoprostol. Obstet. Gynecol. 98:976-977.
DOI
ScienceOn
|
43 |
Carbonell, J. L. L., J. Rodriguez, E. Delagdo, C. Sanchez, F. Vargas, L. Valera, J. Mari, F. Valero, I. Salvador and M. Llorente. 2004. Vaginal misoprostol 800 every 12 h for second-trimester abortion. Contraception 70:55-60.
DOI
ScienceOn
|
44 |
Carlan, S. J., D. Blust and W. F. O'Brien. 2002. Buccal versus intravaginal misoprostol administration for cervical ripening. Am. J. Obstet. Gynecol. 186:229-233.
DOI
ScienceOn
|